Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Creating an informational home pharmacy |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
To reduce 30-day readmission rates for Medicare beneficiaries, our health system:
• Uses pharmacists' medication therapy management skills in hospital-to-home transitions
• Plans to use pharmacists' medication therapy management skills in hospital-to-home transitions within 6 months
• Plans to use pharmacists' medication therapy management skills in hospital-to-home transitions within 12 months
• Has no plans in place to use pharmacists' medication therapy management skills in hospital-to-home transitions
|
|
|
The National Committee for Quality Assurance will release its rules for accountable care organizations in July. Read full article. |
 |
|
|
To confirm your e-newsletter subscription, click here.
To ensure future delivery of email newsletters from
Drug Topics, please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff
|
 |
A monthly review of the
peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS. Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.
|
Risk of VTE recurrence higher for patients with nonsurgical risk factors.
Read full article.
|
NEW YORK (Reuters Health) - Results of a meta-analysis confirm that gefitinib is an effective first-line therapy for advanced non-small-cell lung cancer with EGFR (epidermal growth factor receptor) mutations. Read full article. |
|
NEW YORK (Reuters Health) - In patients with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC), high doses of ursodeoxycholic acid (UDCA) are associated with an increased risk of colorectal neoplasia, a new study shows. Read full article. |
|
NEW YORK (Reuters Health) - The estimated 10-year risk for coronary heart disease (CHD) among adults with diabetes has declined significantly in the past decade, U.S. data show. Read full article. |
|
NEW YORK (Reuters Health) - Men who use inhaled anticholinergics for chronic obstructive pulmonary disease (COPD) have an increased risk of urinary retention, according to a new report. Read full article. |
|
|
Nearly 20% of young adults in the United States may have high blood pressure, according to the National Longitudinal Study of Adolescent Health, an analysis sponsored by the National Institutes of Health and published online in Epidemiology. Read full article.
 |
Meetings and Events
June 25-28, 2011 NACDS Marketplace Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]
July 22-25, 2011 NPhA Annual Convention
Atlanta
Contact:
107 Kilmayne Drive, Suite C
Cary, NC 27511
Phone: 404-262-3344
Fax: 404-262-8689
August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
October 6-7 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
